Gold Member Since 2015
Audited Supplier
Shanghai Yijing Industrial Co., Ltd.

Repaglinide Raw Powder, Anti-Diabetic Drugs Repaglinide, Repaglinide Raw Materials manufacturer / supplier in China, offering Supply High Quality Anti-Diabetic Drugs Repaglinide Raw Powder 135062-02-1, Finished Mixed Injectable Blend Bodybuilding Steroids Liquid Tri Tren 180mg/Ml, Effective Pre-Mixed Raw Powder Injectable Bodybuilding Steroids Tri Deca 300mg/Ml and so on.

(/ )

Supplier Homepage Product Raw chemical materails Supply High Quality Anti-Diabetic Drugs Repaglinide Raw Powder 135062-02-1

Supply High Quality Anti-Diabetic Drugs Repaglinide Raw Powder 135062-02-1

Purchase Qty.:
(g)
10-99 100+
FOB Unit Price: US $0.1 US $0.05
Purchase Qty. (g) FOB Unit Price
10-99 US $0.1
100+ US $0.05
Get Latest Price
Port: Shanghai, China
Production Capacity: 1000kg/Month
Payment Terms: L/C, T/T, Western Union, Money Gram

Request a custom order and have something just for you!

Send Customized Request
Basic Info
  • Model NO.: 135062-02-1
  • Customized: Customized
  • Suitable for: Adult
  • Purity: >99%
  • Appearance: White Crystal or Transparent Powder
  • MW: 452.59
  • Delivery Ways: EMS, DHL, TNT, FedEx, UPS, Toll etc.
  • Transport Package: Discreet Ways for Safe Customs Pass
  • Origin: Shanghai
  • Powder: Yes
  • Certification: GMP, HSE, ISO 9001, USP, BP
  • State: White Crystalline Powder
  • Name: Repaglinide
  • Mf: C27h36n2o4
  • Payment Methods: T/ T, Western Union, Bitcoin, Moneygram
  • Trademark: Yijing Pharma
  • Specification: USP/BP
  • HS Code: 3001200010
Product Description
High Quality Anti-Diabetic Drugs Repaglinide Raw Powder 135062-02-1


Product Name: Repaglinide
CAS: 135062-02-1
MF:C27H36N2O4
MW:452.59
Melting point:129-130.2 °C
Chemical properties:White crystalline powder

Uses 

1. Anti-diabetic medicine. Oral non-sulfonylurea hypoglycemic agent, for the treatment of typediabetes. 
2. Used as hypolycemic agent. 


Dosage and administration    

Tablet: 0.5mg, 1.0mg and 2.0mg. Repaglinide (trade name: NovoNorm) should be taken before main meals (i.e. medicine taken before meals). It would start to promote insulin secretion after 30 minutes of oral administration. Generally speaking the medicine should be taken within 15 minutes before the meal, and the time can also be mastered within 0 to 30 minutes before the meal. Please take repaglinide as directed. Doses vary from person to person and depend on their blood glucose. The recommended starting dose is 0.5mg, which can be adjusted every week or every two weeks as necessary. Patients under treatment of other oral hypoglycemic medicines can be directly transferred to repaglinide treatment, and the recommended starting dose is 1mg. The maximum recommended dose for a single dose is 4mg, taking with meals. But the maximum daily dose should not exceed 16mg. For patients with debilitating and malnutrition, the dose should be carefully adjusted. If combined with metformin, repaglinide dose should be reduced. Although repaglinide is mainly by biliary excretion, renal insufficiency patients still should use with caution.


COA 
 
ContentsSpecificationResults
CharacteristicsA white or yellowish white powder, odorless or almost, a bitter tasteWhite crystalline powder
Identification(1) The positive reactionComplies
(2) The positive reactionComplies
(3) The strongest sorption at wavelength of 259nmThe strongest sorption at wavelength of 260nm
(4) The positive reactionComplies
Inspection
p-Chloroaniline≤0.05%0.02%
Related SubstanceCompliesComplies
Loss on Drying≤3.5%1.0%
Sulphated Ash≤0.1%0.01%
Assay≥97.5% of Chlorhexidine Acetate(on dried basis)99.0 % 

Attentions    

1. Like most other oral hypoglycemic drugs promoting insulin secretion, repaglinide can cause hypoglycemia. When used in combination with metformin, it may increase the risk of hypoglycemia. If after the treatment of combined medication it still sustained high blood glucose, oral hypoglycemic drugs can no longer be used to control blood sugar, and insulin treatment is needed. In the event of stress reaction, such as having a fever, trauma, infection or surgery, it may appear hyperglycemia.

2. As with other oral hypoglycemic agents, patients must use it with caution, to avoid hypoglycemia while driving.

3. Medication overdose may cause hypoglycemia, such as dizziness, sweating, tremor, headache, etc. In response to these reactions, effective measures should be taken to correct hypoglycemia, such as oral sugars. More severe hypoglycemia associated with epilepsy, loss of consciousness or coma, should be intravenous infusion of glucose.

4. Hypoglycemic effect of repaglinide will due to enhanced when in combined use with monoamine oxidase inhibitor (MAOI), non-selective β blockers, angiotensin converting enzyme inhibitor (ACEI), non-steroidal anti-inflammatory drugs, salicylate, octreotide, ethanol and hormones that promote the synthesis of metabolism.

5. It will weaken the hypoglycemic effect when in combination use of oral contraceptives, thiazide drug, corticosteroids, danazol, thyroid hormone and sympathomimetic drug.

6. CYP3A4 inhibitors (such as ketoconazole, itraconazole, and fluconazole), erythromycin and M Bifadier may elevate plasma levels of this product.

7. For drugs able to induce CYP3A4, such as rifampicin or phenytoin, it may reduce the plasma level of this product.
 
Packaging & Delivery:
1.Professionalism and Rich experience
2.Great quality, purity and favourable price
3.Safe and fast delivery
4.Good after-sales service
5.Plenty stock
Other Hot Selling Raw Materials Related
Testosterone EnanthateCAS: 315-37-7
Testosterone PropionateCAS: 57-85-2
Testosterone phenylpropionateCAS: 1255-49-8
Testosterone Sustanon 250Null
Testosterone CypionateCAS: 58-20-8
Trenbolone AcetateCAS: 10161-34-9
Trenbolone EnanthateCAS: 10161-33-8
Trenbolone HexCAS: 23454-33-3
Drostanolone Propionate (Masteron)CAS: 521-12-0
Drostanolone EnanthateCAS: 472-61-145
Boldenone Undecylenate(Equipoise)CAS: 13103-34-9
Nandrolone DecanoateCAS: 360-70-3
Nandrolone PhenylpropionateCAS: 62-90-8
AnavarCAS: 53-39-4
DianabolCAS: 72-63-9
WinstrolCAS: 10418-03-8
AnadrolCAS: 434-07-1
Methenolone Enanthate (Primobolan)CAS: 303-42-4
Methenolone AcetateCAS: 434-05-9
TurinabolCAS: 855-19-6
Send your message to this supplier
Avatar
Mr. Bryan
*From:
To: Mr. Bryan
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

Find Similar Products By Category